SCA
SQZ

Sandy Cove Advisors’s SQZ Biotechnologies Company SQZ Stock Holding History

Sandy Cove Advisors’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-51,707
Closed -$14K – 125
2023
Q2 		$14K Hold
51,707
– – 0.01% 123
2023
Q1 		$29K Hold
51,707
– – 0.02% 89
2022
Q4 		$38.3K Hold
51,707
– – 0.03% 81
2022
Q3 		$118K Hold
51,707
– – 0.11% 73
2022
Q2 		$164K Hold
51,707
– – 0.15% 73
2022
Q1 		$249K Hold
51,707
– – 0.21% 66
2021
Q4 		$462K Buy
+51,707
New +$634K 0.39% 44

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Sandy Cove Advisors's SQZ Position: Q3 2023 in Review

Sandy Cove Advisors sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 51,707 shares — an estimated $14K sold.

Sandy Cove Advisors first reported a position in SQZ in Q4 2021 and held it in 7 quarters. The position peaked at $462K in Q4 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Sandy Cove Advisors reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Sandy Cove Advisors sold 51,707 SQZ Biotechnologies Company shares in Q3 2023, an estimated $14K.
  • Sandy Cove Advisors first reported a position in SQZ Biotechnologies Company in Q4 2021 and held it in 7 quarters.
  • Sandy Cove Advisors's SQZ Biotechnologies Company position peaked at $462K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Sandy Cove Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.